@Xzi I'd totally agree with you if this study was done in a vacuum.
10% effectiveness on a single study is indeed pretty insignificant.
However almost every study has shown some gains.
In fact, 70 out of 81 showed positive effect¹:
Treatment time | Number of studies reporting positive effects | Total number of studies | Percentage of studies reporting positive effects | Probability of an equal or greater percentage of positive results from an ineffective treatment | Random effects meta-analysis results |
Early treatment | 27 | 32 | 84.4% | 1 in 18 thousand | 63% improvement
RR 0.37 [0.28‑0.47]
p < 0.0001 |
Late treatment | 27 | 33 | 81.8% | 1 in 6 thousand | 42% improvement
RR 0.58 [0.45‑0.75]
p < 0.0001 |
Prophylaxis | 16 | 16 | 100% | 1 in 66 thousand | 83% improvement
RR 0.17 [0.11‑0.26]
p < 0.0001 |
All studies | 70 | 81 | 86.4% | 1 in 169 billion | 65% improvement
RR 0.35 [0.29‑0.44]
p < 0.0001 |
Considering ivermectin (IVM from now on) is very cheap and the side effects are pretty mild when they even happen, which is rarely, I'd say that yes, it's
definitely better than placebo.
In the very study we're discussing, it's also seen that IVM, compared to placebo is:
-
35.3% more effective in virus clearance at day 3 (
And that is the real benefit of IVM, as shown by other studies - It somehow greatly delays the virus spread in the body/helps the initial phase of immunity system's containment, and which is why I personally recommend taking it on the onset of symptoms, or as prophylaxis, only in case of direct contact with a suspect case
)
-14.2% more effective in virus clearance at day 7.
The physician who treated me when I got sick in March/2021 is an infectologist, and he is actually a former secretary of health for my state. He has treated over 10k cases of CoViD-19, some using IVM, some not (in association with zinc + vitamin D - 50k UI, when used), and his anecdotal experience is that IVM does make a significant difference.
I favor IVM because it's cheap, with little to no side effects and a proven positive net gain compared to nothing.
And finally, here is an excerpt of one of this study's
authors²:
I don’t understand the psychology of the ivermectin advocates. They fail to see the positive in this study and just focus on it not being overwhelmingly positive. I actually think it is quite positive.
I presented this a couple weeks ago at the NIH Collaboratory Rounds and, if they listened, I advocate that actually, there is a clear signal that IVM works in COVID patients, just that our study didn’t achieve significance.
References:
1 -
https://ivmmeta.com/
2 -
https://stevekirsch.substack.com/p/did-the-together-study-show-that